Nebius Group stock has surged over 60% since May, far outpacing the S&P 500, driven by strong AI infrastructure growth expectations. Q2 sales are projected to jump 83% sequentially, with ultra-high growth expected through 2025 before moderating to double-digit gains in 2026. The company has begun issuing convertible debt to fund expansion, introducing future dilution risk but signaling management's confidence in long-term stock appreciation.
Some discount retailers are seeing improving traffic and sales this year, as consumers are on the hunt for better value. Not all discount stores are experiencing this, but if this is the beginning of a broader shift in consumer behavior, it could be a great buying opportunity for investors looking for potentially undervalued stocks in the retail sector.
Amicus Therapeutics is building momentum with strong sales growth from GALAFOLD and POMBILITI/OPFOLDA, targeting $1 billion in revenue by 2028. The DMX-200 licensing deal opens a major market opportunity in FSGS, with positive interim phase 3 data and potential for broader rare renal indications. Financially, Amicus has limited cash but can raise more through its ATM facility, and its approved drugs are generating double-digit sales growth.
![]() TGT In 1 weeks Announced | Quarterly | $1.14 Per Share |
![]() TGT 2 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 5 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 8 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 11 months ago Paid | Quarterly | $1.12 Per Share |
20 Aug 2025 (In 2 weeks) Date | | 2.08 Cons. EPS | - EPS |
19 Aug 2025 (In 2 weeks) Date | | 2.01 Cons. EPS | - EPS |
21 May 2025 Date | | 1.61 Cons. EPS | 1.3 EPS |
20 May 2025 Date | | 2.02 Cons. EPS | - EPS |
3 Mar 2025 Date | | 2.25 Cons. EPS | 2.41 EPS |
![]() TGT In 1 weeks Announced | Quarterly | $1.14 Per Share |
![]() TGT 2 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 5 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 8 months ago Paid | Quarterly | $1.12 Per Share |
![]() TGT 11 months ago Paid | Quarterly | $1.12 Per Share |
20 Aug 2025 (In 2 weeks) Date | | 2.08 Cons. EPS | - EPS |
19 Aug 2025 (In 2 weeks) Date | | 2.01 Cons. EPS | - EPS |
21 May 2025 Date | | 1.61 Cons. EPS | 1.3 EPS |
20 May 2025 Date | | 2.02 Cons. EPS | - EPS |
3 Mar 2025 Date | | 2.25 Cons. EPS | 2.41 EPS |
Discount Stores Industry | Consumer Defensive Sector | Brian C. Cornell CEO | NYSE Exchange | 87612E106 Cusip |
US Country | 440,000 Employees | 13 Aug 2025 Last Dividend | 20 Jul 2000 Last Split | 6 Apr 1983 IPO Date |
Target Corporation is a prominent general merchandise retailer based in the United States, with its foundations laid in 1902. Its headquarters are located in Minneapolis, Minnesota, marking it as a key player in the American retail sector. The company distinguishes itself through a wide array of products ranging from apparel and beauty products to groceries and electronics, addressing the needs of a diverse consumer base. Beyond its physical stores, Target has embraced the digital era by also offering its products through its website, Target.com. This strategic move ensures its accessibility to a broader audience, leveraging the convenience of online shopping.
Target Corporation presents an extensive variety of products and services, categorized to cater to the needs and preferences of different customer segments:
In addition to its wide product offering, Target enhances the shopping experience with design and creative partnerships, creating unique collections, and also offers shop-in-shop experiences that provide customers with exclusive selections. Further enriching the customer experience are the various in-store amenities offered by Target, making the shopping journey more convenient and enjoyable.